Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Prolight Diagnostics ABNGM:PRLD -5.24%30 3-Year Book Growth Rate is -40.50% as of Jun. 2026. GuruFocus rates NGM:PRLD with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 757 Medical Devices & Instruments companies, Prolight Diagnostics AB ranks worse than 92.21% on this metric.
During the past 12 months, Prolight Diagnostics AB's average Book Value per Share Growth Rate was -15.90% per year.
During the past 3 years, the average Book Value per Share Growth Rate was -40.50% per year.
During the past 5 years, the average Book Value per Share Growth Rate was -35.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 10 years, the highest 3-Year average Book Value per Share Growth Rate of Prolight Diagnostics AB was 29.00% per year. The lowest was -42.90% per year. And the median was -3.00% per year.
Prolight Diagnostics AB (NGM:PRLD) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Prolight Diagnostics AB 3-Year Book Growth Rate Related Terms
NGM:PRLD vs ISRG, BDX, RMD: 3-Year Book Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, Prolight Diagnostics AB's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prolight Diagnostics AB 3-Year Book Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Prolight Diagnostics AB's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Prolight Diagnostics AB's 3-Year Book Growth Rate falls into.
Prolight Diagnostics AB 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of -40.50% mean?
Prolight Diagnostics AB (NGM:PRLD) has a 3-Year Book Growth Rate of -40.50% as of Jun. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Prolight Diagnostics AB and its competitors. According to the industry distribution chart, Prolight Diagnostics AB ranks #698 out of 757 companies in the Medical Devices & Instruments industry, placing it in the top 92.2%.
Is Prolight Diagnostics AB's 3-Year Book Growth Rate too high?
Prolight Diagnostics AB's current 3-Year Book Growth Rate is -40.50%. Based on the distribution chart, Prolight Diagnostics AB ranks #698 out of 757 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Prolight Diagnostics AB has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Prolight Diagnostics AB's 3-Year Book Growth Rate compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Prolight Diagnostics AB ranks #698 out of 757 companies for 3-Year Book Growth Rate. This places Prolight Diagnostics AB in the lower half of its industry. The industry median 3-Year Book Growth Rate is 2.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Medical Devices & Instruments company?
The median 3-Year Book Growth Rate among Medical Devices & Instruments companies is 2.30, based on 757 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Prolight Diagnostics AB and its competitors. For the Medical Devices & Instruments industry, the median 3-Year Book Growth Rate is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prolight Diagnostics AB's current 3-Year Book Growth Rate is -40.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prolight Diagnostics AB stock overvalued right now?
Prolight Diagnostics AB (NGM:PRLD) has a current 3-Year Book Growth Rate of -40.50%. The current 3-Year Book Growth Rate is -40.50%. Prolight Diagnostics AB's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Prolight Diagnostics AB (NGM:PRLD), the current 3-Year Book Growth Rate is -40.50% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Prolight Diagnostics AB along with its subsidiaries, develops Point-of-Care (POC) systems, which are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. Its product portfolio includes Psyros, a digital POC technology, and Microflex.
30GF Score
Get the complete analysis for NGM:PRLD
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGM:PRLD has been successfully added to your 
